Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
NCT00464295
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
Capecitabine in HCC
Sponsor
Aga Khan University